Electroacupuncture in the treatment of neurogenic urine retention through autophagy mediated by AMPK/mTOR pathway.
10.11817/j.issn.1672-7347.2022.210260
- Author:
Zhengfei LI
1
;
Ren ZHANG
2
;
Guorui ZHAO
2
;
Yao KUANG
3
Author Information
1. Department of Massage, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193. lizfe11@163.com.
2. Department of Massage, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193.
3. Department of Massage, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193. 18522006896@163.com.
- Publication Type:Journal Article
- Keywords:
adenine monophosphate activated protein kinase;
autophagy;
electroacupuncture;
mammalian target of rapamycin;
neurogenic urine retention
- MeSH:
AMP-Activated Protein Kinases;
Animals;
Autophagy;
Beclin-1;
Electroacupuncture;
Mammals;
Rats;
Rats, Sprague-Dawley;
Spinal Cord Injuries;
TOR Serine-Threonine Kinases
- From:
Journal of Central South University(Medical Sciences)
2022;47(4):488-496
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Electroacupuncture can enhance autophagic flow, promote neuronal regeneration, axonal and myelin remodeling to achieve the protection of spinal cord injury, but its role in neurogenic urine retention is not completely clear. This study aims to investigate whether the mechanism of electroacupuncture in the treatment of neurogenic urine retention is through autophagy mediated by adenosine monophosphate activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway.
METHODS:A rat model of neurogenic urine retention after sacral spinal cord injury was established. The rats with successful model were randomly divided into a model group, an electroacupuncture group (electro-acupuncture for Ciliao, Zhongji, and Sanyinjiao by electronic stimulation, once a day, 20 min each time for 7 days), and an electroacupuncture+AMP-activated protein kinase (AMPK) inhibitor group (on the basis of the treatment of electroacupuncture group, 100 μg of AMPK inhibitor compound C was injected intramuscularly around the L2-3 intervertebral space on the 1st and 4th day). The normal group did not receive any treatment. The maximum bladder volume, bladder basal pressure, leak point pressure, and bladder compliance were recorded by multi-channel physiological recorder; the morphology of bladder tissue was observed by HE staining; autophagy was observed under transmission electron microscope; the expressions of LC3II and Beclin1 protein were observed by immunofluorescence staining; the protein levels of AMPK, phosphorylated-AMPK (p-AMPK), mTOR, phosphorylated-mTOR (p-mTOR), microtubule associated protein 1 light chain 3 (LC3) II and Beclin1 in bladder tissue were detected by Western blotting.
RESULTS:Compared with the normal group, the maximum bladder capacity, leak point pressure, bladder compliance, p-AMPK, LC3II, Beclin1 protein expressions in the bladder tissue of the model group increased, and the p-mTOR protein expressions were decreased (all P<0.05); compared with the model group, the maximum bladder capacity, bladder compliance, p-mTOR protein expression in the bladder tissue of the electroacupuncture group were decreased, and the p-AMPK, LC3II, and Beclin1 protein expressions were increased (all P<0.05); compared with the electroacupuncture group, the maximum bladder capacity, bladder compliance, p-mTOR protein expression in the bladder tissue of the electroacupuncture+AMPK inhibitor group were increased, the p-AMPK, LC3II, and Beclin1 protein expressions were decreased (all P<0.05). In the model group, the bladder became larger, with unclear and varying degrees of degeneration, severe tissue damage and autophagosome appeared; the bladder of the electroacupuncture group was smaller than that of the model group, and all levels were clearly visible with autophagy bodies; the layers were slightly disordered and damaged in the electroacupuncture + AMPK inhibitor group.
CONCLUSIONS:Electroacupuncture can activate autophagy through AMPK/mTOR pathway, thereby reducing neurogenic urine retention caused by spinal cord injury.
